Case Presentation {#sec1-1}
=================

A 54-year-old female underwent two whole body positron emission tomography/computed tomography (PET/CT) scans before a gadolinium-enhanced magnetic resonance imaging (MRI) of her brain. [Figure 1](#F1){ref-type="fig"} shows the abnormalities found in the brain parenchyma detected by the ^18^F-fluoride PET/CT bone scan, which are more subtle when compared with the somatostatin receptor imaging in [Figure 2](#F2){ref-type="fig"}, using ^68^Ga DOTANOC PET/CT. The two PET/CT scans were performed within a 2-week interval and demonstrate a similar pattern of tracer uptake within the brain parenchyma.

![^18^F-fluoride positron emission tomography/computed tomography bone scan - abnormalities found in the brain parenchyma](WJNM-17-65-g001){#F1}

![^68^Ga DOTANOC positron emission tomography/computed tomography - abnormal uptake in brain parenchyma](WJNM-17-65-g002){#F2}

Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} both correspond to the postgadolinium MRI findings as shown in [Figure 3](#F3){ref-type="fig"}. The histology of the neuroendocrine tumor (NET) demonstrated a Ki67 index of 4.2%, and the size of the NET reduced following the chemotherapy given for the breast cancer making it unlikely to be the source of the cerebral metastases, although brain metastases from NETs have been reported.\[[@ref1]\] Breast cancer has a recognized predisposition to metastasize to the brain;\[[@ref2][@ref3]\] the original histology of the T3 N3, estrogen receptor negative, human epidermal receptor 2 positive invasive ductal carcinoma had a high Ki67 index of 40%, making it more likely to be the responsible primary tumor.\[[@ref4][@ref5]\] Breast cancer has been shown to express somatostatin receptors accounting for the uptake demonstrated on the ^68^Ga DOTANOC PET/CT.\[[@ref6][@ref7]\] In this case, there was no abnormality on the low-dose CTs that accompanied both PET scans and there was an absence of calcification in the areas of increased ^18^F-fluoride uptake within the brain. Extra-osseous findings including brain metastases from breast carcinoma and other primary malignancies have demonstrated uptake on ^18^F-fluoride PET/CT in the absence of calcification, similar to this case.\[[@ref8][@ref9]\] The patient was subsequently admitted for targeted radiotherapy to her cerebral metastases following discussion at multidisciplinary team meetings.

![Magnetic resonance imaging confirming cerebral metastases](WJNM-17-65-g003){#F3}
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